In-Bore Versus Fusion MRI-Targeted Prostate Biopsy of PI-RADS Category 4 or 5 Lesions: A Retrospective Comparative Analysis Using Propensity Score Weighting

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.25207

Shrav Sridhar MD, discusses a retrospective study in which target-specific prostate cancer detection rate in a cohort of patients who underwent in-bore MRI biopsy was compared to the rate in a cohort of patients who underwent ultrasound-MRI fusion-guided biopsy.